Speaker(s): 

Sreelatha Naik, MD, Staff Member, Geisinger - has nothing to disclose.

Moderator(s): 

Anil Singh, MD, Staff Member, Geisinger - has nothing to disclose

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Contrast changes between the 2026 guidelines and 2019 guidelines
• Categorize patients according to risk in acute pulmonary embolism
• Select appropriate treatment strategies based on patient's individual risk

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Anil Kumar Singh, MD, Roop Parlapalli, MD, FHM, FACP, Lakshmi Rani Gollamudi, MD, Christopher DeFrancesco PharmD, RPH, Mary Ellen Berry, PA-C, Alexa Kerecman, CRNP, Michael Madden, DO, and Keshav Bhandari, MD have no identified disclosures. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None